Universe Pharmaceuticals Inc. Class A Ordinary Shares UPC
$5.65
-3.75%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-07-31 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-07-29 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-06-26 | View → |
| 4 | Insider transaction | 2026-05-21 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-05-14 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-04-16 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2026-02-11 | View → |
| 20-F | ANNUAL REPORT | 2026-01-29 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-09-03 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-08-26 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-07-29 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-07-03 | View → |
| 20-F | ANNUAL REPORT | 2025-04-29 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-03-20 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-03-11 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-03-03 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-02-25 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-02-20 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-02-18 | View → |
| 6-K | CURRENT REPORT | 2025-02-11 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-02-03 | View → |
| 6-K | CURRENT REPORT | 2025-01-30 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2024-12-12 | View → |
| 424B5 | PROSPECTUS SUPPLEMENT | 2024-12-09 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2024-11-13 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2024-11-01 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2024-10-10 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2024-09-27 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2024-09-20 | View → |
| 6-K | CURRENT REPORT | 2024-09-03 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2024-07-18 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2024-02-07 | View → |
| 20-F | ANNUAL REPORT | 2024-01-30 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2023-08-31 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2023-08-16 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2023-08-04 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2023-07-27 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2023-07-05 | View → |
| 6-K | CURRENT REPORT | 2023-05-24 | View → |
| 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2023-05-05 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $5.65
- Market Cap
- $3.66 million
- 52-Week Range
- $2.00 – $17.96
- Average Volume
- 1.47 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.